Bangladesh’s Record Measles Surge Exposed Deep Immunity Gaps
Bangladesh is facing its largest measles outbreak on record, and the numbers moved faster than the health system could absorb them. Nationwide surveillance from April 2 through May 27, 2026, identified 67,079 suspected cases and 8,834 confirmed cases across all 8 administrative divisions, with 472 deaths reported among suspected cases and 88 deaths among confirmed cases. The outbreak also overwhelmed facilities: more than 53,000 reported cases, or over 70%, required hospitalization. In a disease with a basic reproduction number estimated at 12–18, even small pockets of susceptibility can fuel explosive transmission once the virus is introduced into a densely populated setting.
One sentence captures the scale of the failure: measles moved through the country faster than routine immunization defenses could contain it.
Children younger than 5 years accounted for 81% of cases, placing the youngest patients at the center of the epidemic. The daily curve climbed rapidly and peaked on April 9, when 1,829 cases were reported in a single day. That surge came before the nationwide vaccination response could take hold, reflecting the time lag between detecting an outbreak, mobilizing doses, and building enough population immunity to blunt transmission. In measles control, the virus often wins the first round because it exploits every delay in response.
Surveillance Data Point to Uneven Protection, Not a Single Localized Failure
The geographic spread tells its own story. Dhaka division recorded the highest incidence at 82.80 cases per 100,000 population, followed by Barishal at 65.63 per 100,000 and Rajshahi at 35.22 per 100,000. Rangpur had the lowest incidence at 7.63 per 100,000. Cases appeared across all 64 districts early in the outbreak, indicating nationwide transmission rather than a single urban cluster. That pattern is consistent with residual immunity gaps rather than a solitary lapse in outbreak control.
Bangladesh’s vaccine history makes the current outbreak more unsettling. The Expanded Programme on Immunization began in 1979, measles vaccine was part of the initial childhood schedule, and coverage improved after introduction of measles-rubella vaccine in 2012 and a second dose in 2015. WHO and UNICEF estimates show first-dose coverage reaching 97% and second-dose coverage reaching 93% by 2023. Yet those national averages masked enough underimmunized children to allow explosive spread. Administrative coverage can look reassuring while local clusters remain vulnerable, especially when denominator estimates lag behind population change and when stockouts disrupt delivery.
The outbreak also exposed weaknesses in surveillance interpretation. A roughly 7:1 gap separated suspected from confirmed cases, which partly reflects standard practice because not every suspected case undergoes laboratory confirmation. The single national laboratory handling measles confirmation also limits throughput. Without case-level linkage between testing and surveillance records, positive predictive value could not be calculated, and the burden measured through confirmed cases likely underestimates the full extent of community transmission. At the bedside and in hospital wards, that means clinicians were seeing only the visible edge of a much wider epidemic.
The case-fatality rates, 0.88% among suspected cases and 0.99% among confirmed cases, demand cautious interpretation. These figures are higher than rates reported in the United States and Europe, but they fall within ranges described in some low- and lower middle-income settings. Because reported cases largely represent children who reached care, and because mild illness in the community is less likely to be captured, the apparent fatality burden may be inflated by referral bias. Severe disease was disproportionately visible because severe disease is what gets counted.
Emergency Vaccination Began After Transmission Was Already Established
Bangladesh moved quickly once the outbreak was recognized. On April 4, 2026, the country notified WHO. The Directorate General of Health Services and the Ministry of Health and Family Welfare activated the Health Emergency Operation Center and rapid response teams, strengthened surveillance, expanded hospital preparedness, provided vitamin A for suspected and confirmed cases, improved isolation and infection prevention capacity, and accelerated vaccine procurement. Targeted vaccination began after the National Immunization Technical Advisory Group approved the response on March 30. A catch-up campaign started on April 5 in 30 upazilas across 18 priority districts, then expanded by April 12 to 30 upazilas, one municipality, and 4 city corporations. A nationwide campaign launched on April 20 and targeted about 18,015,064 children aged 6–59 months.
The campaign’s early coverage was low, at 6% in reports from April 16, before momentum built over the following weeks. By May 13, the campaign had surpassed 100% of the targeted baseline coverage. The rise matters, but so does its timing: the highest weekly case count, 10,427 cases with 62 deaths, occurred during May 7–13, after vaccination coverage had already exceeded the administrative target. The biology of measles explains the lag. Emergency vaccination helps, but protection is not immediate, and a large susceptible reservoir can keep feeding transmission for weeks before case counts bend downward.
Four drivers stand out in the outbreak analysis: a 2024–2025 MR vaccine stockout, gaps in routine immunization, no nationwide MR campaign since 2020, and probable overestimation of administrative coverage from outdated census denominators. Coverage calculations based on 2011 population estimates can make immunization performance appear stronger than it is, especially if migration and demographic change have widened the gap between reported doses and the true target population.
The practical recommendations are direct. Bangladesh needs continued MR vaccination in periurban and other low-coverage areas, stronger caregiver education to improve demand and counter misinformation, reliable routine EPI delivery with adequate stock, and real-time sentinel measles surveillance to detect future outbreaks earlier. The outbreak has already shown what happens when reported coverage and true immunity diverge: measles fills the gap quickly, and it does so in children too young to absorb the consequences of delayed response.